IGM Biosciences, Inc. (IGMS)

NASDAQ: IGMS · Real-Time Price · USD

1.130

0.00 (0.00%)

At close: May 9, 2025, 4:00 PM

1.110

-0.020 (-1.77%)

After-hours: May 9, 2025, 7:47 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Engineered Immunoglobulin M Antibodies	2.13M	Log In
Engineered Immunoglobulin M Antibodies Growth	99.25%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	2.13M	Log In
United States Growth	99.25%	Log In